small molecule

CARBAMAZEPINE

CARBAMAZEPINE

Loss of exclusivity—loss of exclusivity
CompanyANI PHARMACEUTICALS INC

Drug detail

Brand nameCARBAMAZEPINE
Active ingredientCARBAMAZEPINE
Strength200MG
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalMay 2011
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.